Grave diarrhea associated with idelalisib administration

Grave diarrhea associated with idelalisib administration

Bibliographic Details
Main Authors:	David Suárez del Olmo, Laura Corregidor Luna, Francisco José Hidalgo Correas, Elena García Benayas, Benito García Díaz
Format:	Article
Language:	English
Published:	Grupo Aula Médica 2016-05-01
Series:	Farmacia Hospitalaria
Online Access:	http://www.aulamedica.es/fh/pdf/10450.pdf

Similar Items

Polymicrobial lung infection associated with idelalisib administration
by: Eva Lázaro-López, et al.
Published: (2018-01-01)

Pharmaceutical management of the COVID-19 pandemic in a mid-size hospital
by: Laura Corregidor-Luna, et al.
Published: (2020-06-01)

Fatal Outcome for subcutaneous administration of Pegylated IFN alpha 2b in a man with Chronic C hepatitis under treatment with traditional bitherapy
by: Andrea Domínguez Gozalo, et al.
Published: (2015-02-01)

Serious QT interval prolongation associated with velafaxine administration
by: Pilar Tejedor Prado, et al.
Published: (2014-09-01)

Crystal structure of idelalisib tert-butanol monosolvate dihydrate
by: Sven Nerdinger, et al.
Published: (2019-03-01)

Idelalisib may have the potential to increase radiotherapy side effects
by: Thomas Gryc, et al.
Published: (2017-06-01)

Transcriptional Modulation by Idelalisib Synergizes with Bendamustine in Chronic Lymphocytic Leukemia
by: Sara E. F. Kost, et al.
Published: (2019-10-01)

Rapid and complete response to idelalisib in a case of Richter syndrome
by: Bagacean C, et al.
Published: (2019-02-01)

The PI3Kδ Inhibitor Idelalisib Diminishes Platelet Function and Shows Antithrombotic Potential
by: María N. Barrachina, et al.
Published: (2021-03-01)

BCR SIGNALING INHIBITORS: AN OVERVIEW OF TOXICITIES ASSOCIATED WITH IBRUTINIB AND IDELALISIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
by: Lorenzo Falchi, et al.
Published: (2016-02-01)

Idelalisib for the treatment of indolent non-Hodgkin lymphoma: a review of its clinical potential
by: Barrientos JC
Published: (2016-05-01)

Drug Interaction Between Idelalisib and Diazepam Resulting in Altered Mental Status and Respiratory Failure
by: Bossaer, John B., et al.
Published: (2016)

Idelalisib in Combination With Rituximab or Bendamustine or Both in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia
by: Steven E. Coutre, et al.
Published: (2018-06-01)

Lung infiltrates associated with sertraline administration
by: Angel Luis Salcedo Mingoarranz, et al.
Published: (2016-12-01)

A Severe Case of Cutaneous Adverse Drug Reaction Secondary to a Novice Drug: Idelalisib
by: Joseph Gabriel Gabriel MD, et al.
Published: (2017-05-01)

Idelalisib and caffeine reduce suppression of T cell responses mediated by activated chronic lymphocytic leukemia cells.
by: Barry D Hock, et al.
Published: (2017-01-01)

The PI3Kδ Inhibitor Idelalisib Inhibits Homing in an in Vitro and in Vivo Model of B ALL
by: Etai Adam, et al.
Published: (2017-09-01)

Idelalisib in a patient with refractory Waldenström’s macroglobulinemia complicated by anuric renal failure: a case report
by: M. D’Aveni-Piney, et al.
Published: (2018-06-01)

Idelalisib therapy of indolent B-cell malignancies: chronic lymphocytic leukemia and small lymphocytic or follicular lymphomas
by: Madanat YF, et al.
Published: (2016-03-01)

Good Profile of Efficacy/Tolerance of Bortezomib or Idelalisib in Waldenström Macroglobulinemia Associated with Acquired Von Willebrand Syndrome
by: Ojeda-Uribe M, et al.
Published: (2020-02-01)

Management of psoriasis-like rash associated with idelalisib monotherapy in a patient with refractory follicular lymphoma: a case report
by: Salma Machan, et al.
Published: (2020-02-01)

Ab Initio Spectroscopic Investigation of Pharmacologically Relevant Chiral Molecules: The Cases of Avibactam, Cephems, and Idelalisib as Benchmarks for Antibiotics and Anticancer Drugs
by: Elena Molteni, et al.
Published: (2021-04-01)

The PI3K∂-Selective Inhibitor Idelalisib Induces T- and NK-Cell Dysfunction Independently of B-Cell Malignancy-Associated Immunosuppression
by: Lisa Rohrbacher, et al.
Published: (2021-03-01)

Copanlisib for treatment of B-cell malignancies: the development of a PI3K inhibitor with considerable differences to idelalisib
by: Krause G, et al.
Published: (2018-08-01)

Sequential Kinase Inhibition (Idelalisib/Ibrutinib) Induces Clinical Remission in B-Cell Prolymphocytic Leukemia Harboring a 17p Deletion
by: H. Coelho, et al.
Published: (2017-01-01)

Splenic rupture in a patient with advanced gastric cancer receiving ramucirumab
by: Esther Legaria Gaztambide, et al.
Published: (2016-07-01)

Idelalisib addition has neutral to beneficial effects on quality of life in bendamustine/rituximab-treated patients: results of a phase 3, randomized, controlled trial
by: Marco Montillo, et al.
Published: (2019-11-01)

Nabilone administration in refractory chronic diarrhea: a case series
by: Lanfranco Pellesi, et al.
Published: (2019-06-01)

The PI3-kinase delta inhibitor idelalisib (GS-1101) targets integrin-mediated adhesion of chronic lymphocytic leukemia (CLL) cell to endothelial and marrow stromal cells.
by: Stefania Fiorcari, et al.
Published: (2013-01-01)

Combined administration of antibiotics increases the incidence of antibiotic-associated diarrhea in critically ill patients
by: Ma H, et al.
Published: (2019-05-01)

Intractable chronic diarrhea associated with phenotypic diarrhea of infancy (tricho-hepato-enteric syndrome)
by: José Francisco Cadena-León, et al.
Published: (2014-11-01)

Oral administration of chestnut tannins to reduce the duration of neonatal calf diarrhea
by: F. Bonelli, et al.
Published: (2018-07-01)

No relation between docetaxel administration route and high‐grade diarrhea incidence
by: Jeroen J. M. A. Hendrikx, et al.
Published: (2020-08-01)

Combination of the PI3K inhibitor Idelalisib with the conventional cytostatics cytarabine and dexamethasone leads to changes in pathway activation that induce anti-proliferative effects in B lymphoblastic leukaemia cell lines
by: L.-M. Sklarz, et al.
Published: (2020-08-01)

Oral Administration of Astrovirus Capsid Protein Is Sufficient To Induce Acute Diarrhea In Vivo
by: Victoria A. Meliopoulos, et al.
Published: (2016-11-01)

Prevalence of Clostridium Difficile- Associated Diarrhea in Hospitalized Patients with Nosocomial Diarrhea
by: N Sadeghifard, et al.
Published: (2005-09-01)

Prevalence of Clostridium Difficile- Associated Diarrhea in Hospitalized Patients with Nosocomial Diarrhea
by: N Sadeghifard, et al.
Published: (2005-12-01)

Diarrhea
by: Hamid Kalantari
Published: (2011-07-01)

Diarrhea Recurrence in Patients with Clostridium difficile-Associated Diarrhea: Role of Concurrent Antibiotics
by: MJ Alfa, et al.
Published: (1999-01-01)

Evaluation of antibiotic administration for the treatment of acute pediatric diarrhea, Besat Hospital, Sanandaj, 2016
by: Pedram Ataee, et al.
Published: (2020-10-01)

Cannot write session to /tmp/vufind_sessions/sess_0dho3v6vj9ejk1i6d3f1urv186